Search results for: 'software revenue m9de'
- Did you mean
- software revenue more
- software revenue model
- Related search terms
- Software-Defined Instruments and Reinvented Business Models to Impact Market Outlook, Communication Test Revenues to Soar
- Software-as-a-Service Value Proposition - A Look Under the Hood
- revenue estimates for payment fraud prevention services
- revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related test
- m9de based system engineering market
-
02 Jun 2020  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence for Healthcare IT, Global, 2020
Benchmarking Future Growth Potential
Frost & Sullivan research has identified the core areas in which artificial intelligence (AI)-enabled healtchcare IT solutions are most relevant for hospitals, physicians, and payers. Hospitals that have so far invested in AI-based financial solutions to automate patient access management, reimbursement eligibility matching, and computer-assisted ...
$4,950.00 -
21 May 2021  |  North America  |  Market Research
Explosion of Data Drives the US Social Determinants of Health Market
Proven Returns on Investment will Ignite Transformational Growth
This report from Frost & Sullivan Healthcare and Life Sciences focuses on the potential to cater to healthcare needs based on data-driven social determinants of health (SDOH). Although the traditional practice of healthcare involves the use of medical technology and protocols to maintain and restore health, the SDOH concept adds another dimension. ...
$2,450.00 -
01 Feb 2022  |  Global  |  Frost Radar
Frost Radar™: Global Enterprise Health Cloud Infrastructure and Platform Services, 2021
A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines
The COVID-19 pandemic has revealed that many healthcare organizations have neither the agility and business continuity programs nor the technologies needed to support them during a crisis. Consequently, some have been forced to act on cloud and digital transformation strategies they had been delaying. The cloud has been critical in helping healthca...
$4,950.00 -
23 Dec 2020  |  North America  |  Market Research
Growth Opportunity Analysis of the North American Clinical Documentation Improvement (CDI) Market
Internal Challenges, Disruptive Technologies, and Competitive Intensity are Driving CDI to become a More Value-based Process
This Frost & Sullivan research service presents a comprehensive overview of the North American clinical documentation improvement (CDI) market. CDI is a mid-process in the broader revenue cycle management (RCM) ecosystem. This study analyzes key product segments, major end users, and top vendors across the United States and Canada. Revenue is fo...
$4,950.00 -
23 Apr 2025  |  North America  |  Frost Radar
Frost Radar™: Clinical Documentation Integrity in North America, 2025
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
As the healthcare industry shifts from a fee-for-service to a fee-for-value model, value-based reimbursement is becoming the standard for accountable care organizations (ACOs), independent physician practices, and non-ACO entities. This transition underscores the essential role of clinical documentation integrity (CDI) specialists, medical coders, ...
$4,950.00 -
03 Feb 2017  |  Latin America  |  Market Research
Mobile Health and Telemedicine Markets in Brazil, Forecast to 2020
Tele-imaging, Connected Devices, and Distance Learning Offer Value Propositions in an Infant Telehealth Industry
Brazil’s telemedicine market is likely to increase from $495.3 million in 2015 to $743.8 million in 2017 whereas the mHealth market revenue will grow from $446.8 million to $1.43 billion over the same period. Telemedicine is strongly focused on teleradiology in Brazil, which represents over 98% of the market segment revenue. Other telemedicine appl...
$3,000.00 -
12 Nov 2020  |  South Asia, Middle East & North Africa  |  Market Research
Strategic Public-Private Partnerships Transforming the Telehealth Market in the KSA and the UAE, 2020–2025
Future Growth Potential of Country-level Telehealth Initiatives that Create Multimillion-dollar Growth Opportunities
In this research service, Frost & Sullivans transformational health team provides critical insights into the KSA and UAE telehealth markets and highlights growth opportunities, revenue segments, and technology trends that influence growth and revenue. The telehealth market covered in this study includes three segments: virtual visits, mHealth, and...
$4,950.00 -
09 Oct 2019  |  North America  |  Frost Radar
Frost Radar in the US Healthcare Data Analytics Market
A Measurement System to Spark Companies 2 Action (C2A)—Innovation That Fuels New Deal Flow and Growth Pipelines
US-based providers lose an estimated $260 billion to $270 billion annually due to poor financial risk management and lack of infrastructure to support data-driven business decisions. For every dollar claimed, private and public payers on average offer a reimbursement of 86 cents to providers, resulting in a negative margin of 14% per dollar per pat...
$4,950.00 -
28 Apr 2026  |  Global  |  Market Research
Global Digital Health Solutions for Behavioral Health Management, Forecast to 2031
Platformization, Enterprise Adoption, and AI-Enabled Care are Redefining Behavioral Health Delivery
The global digital health solutions market for behavioral health management is demonstrating steady and sustained growth, driven by rising demand for accessible, scalable mental health services across employers, payers, and health systems. Persistent workforce shortages, increasing prevalence of mental health conditions, and growing recognition of ...
$4,950.00 -
23 Jul 2021  |  North America  |  Market Research
US Digital Therapeutics Growth Opportunities
Transformational Growth in New Business Models After COVID-19
Patients with long-term chronic conditions and rare diseases are looking for safe, novel, and evidence-based digital treatments in their pursuit to reduce dosages and reverse triggers of adverse events. Payers and providers are looking for legitimate alternatives to expensive medication for their patient population. Life sciences (LS) companies are...
$4,950.00